CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 30 SECOND OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW

CLICK HERE TO READ OUR 3 MINUTE OVERVIEW

CORPORATE OBJECTIVE


“To build a global biotechnology-pharmaceutical business around two first-in-class drug technology platforms.


To bring both drug technology platforms onto the market as standard first-line therapies for most forms of cancer.”


Dr Graham Kelly, Executive Chairman

CLICK HERE TO READ OUR INVESTOR PRESENTATION

CLICK HERE TO READ OUR INVESTOR PRESENTATION

CLICK HERE TO READ OUR INFORMATION MEMORANDUM

CLICK HERE TO READ OUR INFORMATION MEMORANDUM

 

CAPITAL RAISING INFORMATION


More information about ASX BookBuild
Information on the ASX BookBuild Facility can be found on the ASX website on the links below.

CONTACT DETAILS

Novogen Enquiries
Dr Graham Kelly
CEO Novogen Group

Graham.Kelly@novogen.com
+(61 2) 9472 4100

Advisor to the Offer
Matt Christensen
Hill Capital

matthewc@hillcapital.com.au
+(61 2) 9416 5399

Media Enquiries
Ian Westbrook
Westbrook Communications

ian@westbrookfin.com.au
+(61 2) 9231 0922